Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Type 1 diabetes is a serious disease that affects how the body controls sugar in the blood. People with this condition cannot ...

A conserved glucagon signaling pathway links high-fat diet-induced metabolic imbalance to cardiac arrhythmia through hormone-producing cells and heart-innervating neurons that regulate rhythmicity.

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

At the Medical University of South Carolina (MUSC), researcher Leonardo Ferreira, Ph.D., is leading an ambitious effort to change how type 1 diabetes ...

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

Explore the breakthrough therapy that offers hope to cure type 1 diabetes by restoring insulin-producing beta cells ...